Evidence map›Paper›PMID 40005074›Full record

ArticleMolecules (Basel, Switzerland)2025

Microbial Transglutaminase-The Food Additive, a Potential Inducing Factor in Primary Biliary Cholangitis.

Alicja Bauer, Paulina Rosiek, Tomasz Bauer

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alicja BauerDepartment of Biochemistry and Molecular Biology, Centre of Postgraduate Medical Education, Marymoncka 99/103, PL-01-813 Warsaw, Poland.ORCID 0000-0003-2051-1177
Paulina RosiekFaculty of Chemistry, University of Warsaw, L Pasteura 1, PL-02-093 Warsaw, Poland.ORCID 0000-0003-2584-3680
Tomasz BauerFaculty of Chemistry, University of Warsaw, L Pasteura 1, PL-02-093 Warsaw, Poland.ORCID 0000-0001-5899-7454

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial transglutaminase (mTG) is a bacterial survival factor, which is frequently used as a food additive. This results in the formation of immunogenic epitopes that may cause autoimmunity. Primary biliary cholangitis (PBC) is a cholestatic, autoimmune liver disease characterized by the presence of characteristic autoantibodies. The aim of this work was to determine epitope similarity and cross-reactivity between mTG- and PBC-specific antigens and to investigate whether the microbial enzyme may be associated with the induction of autoimmunity due to epitope similarity and cross-reactivity. Monoclonal and polyclonal antibodies against mTG were applied to nine different PBC-specific antigens using ELISA technique. They reacted significantly with four out of nine antigens. This reaction was most pronounced for gp210 and PML protein. We also performed in vitro studies on the impact of the mTG on the specific antigen-antibody binding using sera of PBC patients. We found four PBC-specific antigens that share homology with mTG sequences. We noticed inhibition of this specific binding by the mTG to the PDC M2, gp210, PML, and KLHL12 protein. Microbial mimics may be the major targets of cross-reactivity with human-specific antigens. Cross-reactivity may indicate a link between mTG and the development of autoimmune diseases.

Indexed as

Bacterial ProteinsFood AdditivesLiver Cirrhosis, BiliaryTransglutaminasesAutoantibodiesAutoantigensCross ReactionsEpitopesHumansAutoantibodiesAutoantigensBacterial ProteinsEpitopesFood AdditivesTransglutaminasesautoimmunitymicrobial transglutaminasemolecular mimicryprimary biliary cirrhosis

Identifiers

PMID40005074
PMCPMC11858182

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.